Development of acute myeloblastic leukaemia in a case of aplastic anaemia treated with granulocyte colony-stimulating factor

Br J Haematol. 1994 Jul;87(3):666-8. doi: 10.1111/j.1365-2141.1994.tb08339.x.

Abstract

We report a case of aplastic anaemia (AA) treated with granulocyte colony-stimulating factor (G-CSF) terminating as acute myeloblastic leukaemia (AML). Because of severe pneumonia, 250 micrograms of G-CSF was administered for 30 d to promote neutrophil recovery. Following G-CSF therapy, myeoblasts appeared, and the diagnosis of AML was then made. The myeloblasts proliferated in response to G-CSF in vitro and in vivo. In AA, development of AML after treatment with G-CSF is rare. Therefore a careful observation for leukaemic transformation is necessary in long-term administration of G-CSF for AA.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anemia, Aplastic / immunology
  • Anemia, Aplastic / pathology
  • Anemia, Aplastic / therapy*
  • Bone Marrow / pathology
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / etiology*
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / pathology
  • Lymphocyte Activation

Substances

  • Granulocyte Colony-Stimulating Factor